Literature DB >> 23434440

Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle?

Noémie Péan1, Isabelle Doignon, Thierry Tordjmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23434440     DOI： 10.1016/j.clinre.2012.12.005

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  5 in total

1.  Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.

Authors:  Guoxiang Xie; Xiaoning Wang; Fengjie Huang; Aihua Zhao; Wenlian Chen; Jingyu Yan; Yunjing Zhang; Sha Lei; Kun Ge; Xiaojiao Zheng; Jiajian Liu; Mingming Su; Ping Liu; Wei Jia
Journal:  Int J Cancer       Date:  2016-06-17       Impact factor: 7.396

2.  The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.

Authors:  Yongqing Wang; Hiroaki Aoki; Jing Yang; Kesong Peng; Runping Liu; Xiaojiaoyang Li; Xiaoyan Qiang; Lixin Sun; Emily C Gurley; Guanhua Lai; Luyong Zhang; Guang Liang; Masayuki Nagahashi; Kazuaki Takabe; William M Pandak; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

Review 3.  Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.

Authors:  Wei Jia; Guoxiang Xie; Weiping Jia
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

4.  Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences.

Authors:  Chunhong Pang; Amy LaLonde; Tony E Godfrey; Jianwen Que; Jun Sun; Tong Tong Wu; Zhongren Zhou
Journal:  Clin Exp Gastroenterol       Date:  2017-02-07

5.  Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.

Authors:  Rui Shen; Lixin Ke; Qiao Li; Xi Dang; Shunli Shen; Jianming Shen; Shaoqiang Li; Lijian Liang; Baogang Peng; Ming Kuang; Yi Ma; Zhonghan Yang; Yunpeng Hua
Journal:  Hepatol Int       Date:  2022-02-24       Impact factor: 9.029
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.